𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prompt engraftment using autologous peripheral blood stem cells for double autologous bone marrow rescue

✍ Scribed by Christopher D. Hillyer; Raymond L. Comenzo; Kenneth B. Miller; David P. Schenkein; Karen O. Tiegerman; Terry A. Fogaren; David E. Wazer; Leroy Parker; Ross A. Abrams; Jane F. Desforges; Richard A. Rudders; Eugene M. Berkman

Publisher
John Wiley and Sons
Year
1991
Tongue
English
Weight
181 KB
Volume
36
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Autologous bone marrow versus non-mobili
Autologous bone marrow versus non-mobilized peripheral blood stem cell transplantation for lymphoid malignancies: A prospective, comparative trial
✍ Weisdorf, Daniel J.; Verfaillie, Catherine M.; Miller, Wesley J.; Blazar, Bruce πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 61 KB πŸ‘ 2 views

## Autologous transplantation using bone marrow stem cells (BMSC) or peripheral blood stem cells (PBSC) is widely used for non-Hodgkin 's lymphoma (NHL) and Hodgkin's disease (HD). We report a randomized, comparative trial comparing BMSC vs. nonmobilized PBSC for responsive NHL or HD. Patients ran

Immunotherapy using autologous monocyte-
Immunotherapy using autologous monocyte-derived dendritic cells pulsed with leukemic cell lysates for acute myeloid leukemia relapse after autologous peripheral blood stem cell transplantation
✍ Je-Jung Lee; Hoon Kook; Myong-Suk Park; Jong-Hee Nam; Bo-Hwa Choi; Won-Hyun Song πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 135 KB

Although a second stem cell transplantation (SCT) can be used as salvage therapy in patients with relapsing leukemia after SCT, most of these patients have a poor outcome. We tried clinical vaccination using monocyte-derived dendritic cells (DCs) pulsed with leukemic lysates to treat relapsing acute

Treatment of refractory and relapsed Hod
Treatment of refractory and relapsed Hodgkin's disease: Intensive chemotherapy and autologous bone marrow or peripheral blood stem cell support
✍ Hurd, David D. ;Haake, Robert J. ;Lasky, Larry C. ;Christiansen, Neal P. ;McGlav πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 719 KB

## Abstract Thirty‐three patients with recurrent or refractory Hodgkin's disease were treated with high‐dose cyclophosphamide, BCNU, and etoposide and supported with either autologous bone marrow or peripheral blood stem cells or both. Peripheral blood stem cells were comparable to bone marrow in s